Atropine Dosing for Organophosphate Poisoning

Initial Dosing Algorithm

The American Heart Association recommends an initial atropine dose of 1-2 mg IV for adults and 0.02 mg/kg IV for children, with a minimum dose of 0.1 mg and a maximum single dose of 0.5 mg in pediatrics, for the treatment of organophosphate poisoning 1, 2
The initial dose for adults is substantially higher than the 0.5-1.0 mg used for bradycardia from other causes, highlighting the need for aggressive treatment in organophosphate poisoning cases 1

The key principle in atropine dosing for organophosphate poisoning is aggressive, rapid escalation, with the dose doubled every 5 minutes until atropinization endpoints are reached, as recommended by the American Heart Association 1, 3, 2
This doubling strategy is critical and differs from fixed-dose repetition, emphasizing the importance of tailored treatment approaches 1
Continuation of escalation regardless of heart rate is crucial, as tachycardia is not a contraindication to continued dosing, according to the American Heart Association guidelines 2, 4

The American Heart Association guidelines specify that atropine dosing should be stopped when all of the following endpoints are achieved: clear chest on auscultation, heart rate >80 beats/min, systolic blood pressure >80 mm Hg, dry skin and mucous membranes, and mydriasis (pupil dilation) 1, 4

After achieving initial atropinization, maintenance therapy involves administering 10-20% of the total loading dose per hour, up to 2 mg/h in adults, as recommended by the American Heart Association 1, 3
Continuous infusion is preferred over intermittent boluses for maintenance, according to the American Heart Association guidelines 2, 4

The American Heart Association emphasizes that atropine administration should never be delayed, as it is the immediate life-saving intervention with Class 1, Level A evidence for severe organophosphate poisoning 2, 5
Underdosing should be avoided, as organophosphate poisoning often requires high total doses of atropine, and the therapeutic endpoint is control of muscarinic symptoms, not heart rate normalization 2, 4
Essential concurrent therapies include pralidoxime, benzodiazepines for seizures and agitation, and early endotracheal intubation for life-threatening poisoning, as recommended by the American Heart Association 2, 4, 5

The American Society of Anesthesiologists reports that cumulative doses of atropine may reach 10-20 mg in the first 2-3 hours, with some patients requiring up to 50 mg in 24 hours, in the treatment of organophosphorus poisoning 6
Organophosphates form irreversible bonds with acetylcholinesterase that undergo "aging," and restoration of normal enzyme activity may take up to 6 weeks in untreated patients, highlighting the need for prolonged atropinization 6

The American Society of Anesthesiologists emphasizes that repeated doses of atropine must be readministered "as deemed clinically necessary" in the treatment of organophosphorus poisoning 6